The WHO recommendations encourage the adoption of those technologies, delivered they may be validated to demonstrate equivalent or outstanding effectiveness in comparison with standard procedures. Manufacturers wanting to put into practice these strategies must deliver strong validation knowledge to display their equivalence to pharmacopoeia